Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Konrad Beyreuther awarded with the first Hartwig Piepenbrock-DZNE Prize

02.09.2011
The first "Hartwig Piepenbrock-DZNE Prize" for outstanding research in the field of neurodegenerative diseases will be awarded to the renowned Alzheimer researcher Prof. Konrad Beyreuther, Heidelberg University.

The award honors Beyreuther for the discovery of the nature of the amyloid protein, the key component of plaques found in brains of individuals suffering from Alzheimer's disease. The prize, endowed with 60,000 Euros, is donated by the Piepenbrock Group and recognizes outstanding scientific contributions towards the understanding, prevention and cure of neurodegenerative disorders such as Alzheimer's and Parkinson's diseases. The award is decided by an international scientific committee coordinated by the German Centre for Neurodegenerative Diseases (DZNE).

The award ceremony will take place at the scientific conference on "Ageing and Neurodegeneration" (Schloss Bensberg, Bergisch Gladbach). The guests will be welcomed by Olaf Piepenbrock, CEO and Chairman of Piepenbrock Group. Prof. Pierluigi Nicotera, Scientific Director of the DZNE, will give a tribute speech, the prize will be awarded by benefactress Maria-Theresia Piepenbrock.

Background
A key feature of Alzheimer's disease is the formation of protein deposits in the brains of patients associated with progressive neuronal cell damage and eventually cell death. In the 1980’s – almost 80 years after the German physician Alois Alzheimer discovered these so called "Alzheimer plaques" – Konrad Beyreuther successfully identified their biochemical composition. This groundbreaking discovery marked the beginning of the molecular study of Alzheimer's disease, a hitherto entirely obscure disorder. In the decades to follow, Beyreuther has continued his work to elucidate the causes of Alzheimer's disease. He and his colleagues were able to identify how the protein deposits arise and how this process could be inhibited in laboratory models. There is as yet no cure for Alzheimer's disease. But there is well-founded hope that recent research progress will lead to the development of effective new therapies within the next 10-15 years – and to this, Beyreuther has contributed significantly.
The awardee
Konrad Beyreuther received his Ph.D. in 1968 at the Max Planck Institute for Biochemistry in Munich. From 1968 to 1987 he performed his research work at the Institute of Genetics at the Albertus Magnus University of Cologne, and became professor in 1980. From 1987 to 2007 Beyreuther was professor at the Zentrum für Molekulare Biologie der Universität Heidelberg (ZMBH) and since 2006 he has led the Network Aging Research at the Heidelberg University. Beyreuther has received several awards for his research on the molecular understanding of Alzheimer's disease. In addition, he served as a member of the Baden-Wuerttemberg state government in the role of State Councillor for the Protection of Life and Health, from 2001 to 2006.
About Piepenbrock
The Piepenbrock Group is an owner-managed family business, now in its fourth generation. Piepenbrock provides its clients with a broad range of services, e.g. in the areas of facility management, cleaning services, maintenance and security services. With its affiliated companies LoeschPack and Hastamat, Piepenbrock successfully produces packaging machines. The Piepenbrock Group has a long tradition of promoting sports, environmental protection and arts. Piepenbrock now adds support of neurodegenerative disease research to its social commitments, in recognition of the profound impact these disorders impose on patients, families and carers.
About DZNE
The DZNE was established as a research center in the Helmholtz Association in 2009 with the goals of investigating the underlying causes of neurodegenerative diseases and developing new interventions and health care strategies to combat them. Research activities within the DZNE network of nine sites cover the entire scientific spectrum, from the investigation of molecular processes in neurons, to clinical and population-based sciences and to health care systems research.

Katrin Weigmann | idw
Further information:
http://www.dzne.de/
http://www.zmbh.uni-heidelberg.de/Beyreuther/

More articles from Awards Funding:

nachricht Extensive Funding for Research on Chromatin, Adrenal Gland, and Cancer Therapy
28.06.2017 | Helmholtz Zentrum München - Deutsches Forschungszentrum für Gesundheit und Umwelt

nachricht Otto Hahn Medal for Jaime Agudo-Canalejo
21.06.2017 | Max-Planck-Institut für Kolloid- und Grenzflächenforschung

All articles from Awards Funding >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: 3-D scanning with water

3-D shape acquisition using water displacement as the shape sensor for the reconstruction of complex objects

A global team of computer scientists and engineers have developed an innovative technique that more completely reconstructs challenging 3D objects. An ancient...

Im Focus: Manipulating Electron Spins Without Loss of Information

Physicists have developed a new technique that uses electrical voltages to control the electron spin on a chip. The newly-developed method provides protection from spin decay, meaning that the contained information can be maintained and transmitted over comparatively large distances, as has been demonstrated by a team from the University of Basel’s Department of Physics and the Swiss Nanoscience Institute. The results have been published in Physical Review X.

For several years, researchers have been trying to use the spin of an electron to store and transmit information. The spin of each electron is always coupled...

Im Focus: The proton precisely weighted

What is the mass of a proton? Scientists from Germany and Japan successfully did an important step towards the most exact knowledge of this fundamental constant. By means of precision measurements on a single proton, they could improve the precision by a factor of three and also correct the existing value.

To determine the mass of a single proton still more accurate – a group of physicists led by Klaus Blaum and Sven Sturm of the Max Planck Institute for Nuclear...

Im Focus: On the way to a biological alternative

A bacterial enzyme enables reactions that open up alternatives to key industrial chemical processes

The research team of Prof. Dr. Oliver Einsle at the University of Freiburg's Institute of Biochemistry has long been exploring the functioning of nitrogenase....

Im Focus: The 1 trillion tonne iceberg

Larsen C Ice Shelf rift finally breaks through

A one trillion tonne iceberg - one of the biggest ever recorded -- has calved away from the Larsen C Ice Shelf in Antarctica, after a rift in the ice,...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

Closing the Sustainability Circle: Protection of Food with Biobased Materials

21.07.2017 | Event News

»We are bringing Additive Manufacturing to SMEs«

19.07.2017 | Event News

The technology with a feel for feelings

12.07.2017 | Event News

 
Latest News

Ultrathin device harvests electricity from human motion

24.07.2017 | Power and Electrical Engineering

Scientists announce the quest for high-index materials

24.07.2017 | Materials Sciences

ADIR Project: Lasers Recover Valuable Materials

24.07.2017 | Materials Sciences

VideoLinks
B2B-VideoLinks
More VideoLinks >>>